Effect of Intraarticular Injection of Tenoxicam and Hyaluronic Acid Versus Platelet-Rich Plasma and Hyaluronic Acid in Temporomandibular Joint Internal Derangement

NCT06572904 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Temporomandibular Joint Internal Derangement

Interventions

DRUG: Tenoxicam Injectable Product
DRUG: Hyaluronic Acid 20 MG/1 ML Injection Gel/Jelly

Sponsor

Mansoura University